CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...